About METABA LLC
Metaba is a privately held preclinical biopharmaceutical company focused on developing life-saving therapies for infectious diseases using innovative, hypothesis-driven strategies. The company leverages its novel oxysterol-based antimicrobial platform to address antimicrobial resistance and develop first-in-class antibiotic solutions.
Development of semi-synthetic, orally bioavailable, oxysterol-based compounds with bactericidal activity against drug-resistant Mycobacterium tuberculosis (Mtb)Collaboration with leading global pharmaceutical companies and research institutionsDesign and evaluation of safer, more effective, first-in-class therapies for infectious diseasesStrategic leadership in biopharmaceutical advancements through partnerships and alliances
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to METABA LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.